REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmalex, Spol. S R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Farmalex, Spol. S R.O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Farmalex, Spol. S R.O. is based in Slovakia, with the head office in Presov. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on October 17, 1995. The total number of employees is currently 3 - 4 (2025). There was a net sales revenue drop of 87.87% reported in Farmalex, Spol. S R.O.’s latest financial highlights for 2025. Its’ total assets recorded a negative growth of 16.24%. The net profit margin of Farmalex, Spol. S R.O. decreased by 7.12% in 2025.

Headquarters
Holleho, 14/A
Presov; Presovsky; Postal Code: 08001

Contact Details: Purchase the Farmalex, Spol. S R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Farmalex, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Farmalex, Spol. S R.O. report to view the information.
Financial Auditors:
Purchase the Farmalex, Spol. S R.O. report to view the information.
Incorporation Date:
October 17, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
85%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Farmalex, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-87.87%
Total Operating Revenue
-88.02%
Operating Profit
69.24%
EBITDA
N/A
Net Profit/Loss for the Period
75.9%
Total Assets
-16.24%
Total Equity
-5.13%
Operating Profit Margin
-9.48%
Net Profit Margin
-7.12%
Return on Equity (ROE)
15.87%
Debt / Equity
-31.21%
Quick Ratio
-0.02%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?